← News & Insights

News

Company news, scientific announcements, press releases, and media coverage from Constructive Bio.

All News

  • All
  • Award
  • Company
  • Event
  • Featured
  • News
  • Press
  • Publication
Constructive Bio Jason Chin Heinrich Weiland Prize

June 25, 2026

Constructive Bio Founder and Chief Scientific Officer, Professor Jason Chin, named the 2026 Heinrich Wieland Prize recipient

March 10, 2026

Constructive Bio shortlisted for One Nucleus Awards 2026: best use of emerging technology

Constructive Bio's 2025 ncAA Milestones

January 26, 2026

Constructive Bio’s 2025 Milestones in Non-Canonical Amino Acid (ncAA) Biomanufacturing

Constructive Bio Selected as Nature Biotechnology 2025 Editor’s Pick for Synthetic Genomics and ncAA Platform

January 5, 2026

The Observer Features Constructive Bio’s Sustainable Fermentation Alternative to Peptide Manufacturing Waste

SynBioBeta featured an interview with Constructive Bio founder and CSO Professor Jason Chin on expanded genetic codes and novel polymer applications at the iGEM Grand Jamboree in Paris.

November 20, 2025

SynBioBeta Interviews Professor Jason Chin on Constructive Bio’s Expanded Genetic Code and Novel Polymer Applications

Constructive Bio and RxCelerate have partnered to combine programmable biology and ncAA-enabled protein engineering with drug design and development capabilities, targeting next-generation biologics for challenging diseases.

November 19, 2025

Constructive Bio Partners with RxCelerate to Advance ncAA-Containing Biologics Through Drug Design and Development

Constructive Bio Selected as Nature Biotechnology 2025 Editor’s Pick for Synthetic Genomics and ncAA Platform

October 11, 2025

Constructive Bio Selected as Nature Biotechnology 2025 Editor’s Pick for Synthetic Genomics and ncAA Platform

Constructive Bio entered a collaboration with the Ellison Institute of Technology's Generative Biology Institute (GBI) in Oxford, combining synthetic genome platforms to advance new medicines, disease-resistant cells, and sustainable materials.

October 10, 2025

Constructive Bio Collaborates with Ellison Institute’s Generative Biology Institute

Constructive Bio hosted the Cambridge iGEM 2025 team at The Recodery for a technical discussion on synthetic biology research, as part of ongoing engagement with emerging researchers in genome engineering.

September 23, 2025

Cambridge iGEM 2025 Team Visits Constructive Bio’s Recodery for Synthetic Biology Discussion

Constructive Bio Wins Life Science Scale-Up Award at the Business Weekly Awards, Cambridge

September 15, 2025

Constructive Bio Wins Life Science Scale-Up Award at the Business Weekly Awards, Cambridge

Constructive Bio is contributing its large-scale genome assembly platform to an ARIA-funded collaboration with Camena Bioscience and the Max-Planck Institute to develop synthetic chloroplast genomes for multiple plant species.

August 14, 2025

Constructive Bio Joins ARIA-Funded Collaboration to Build Synthetic Chloroplast Genomes Using Large-Scale DNA Assembly

The New York Times covered the creation of Syn57, an E. coli strain with a 57-codon synthetic genome — the most radically recoded organism ever made — by the MRC LMB team led by Constructive Bio's founder, Professor Jason Chin.

August 1, 2025

Syn57: MRC LMB Team Led by Constructive Bio’s Jason Chin Creates E. coli with 57-Codon Synthetic Genome

June 10, 2025

Constructive Bio Sponsors 2025 LMB–Institut Pasteur Symposium on Molecular Biology Research

Constructive Bio Licences Trna Display Tech

June 4, 2025

Constructive Bio Licences tRNA Display Technology for Incorporating Non-Canonical Amino Acids into Peptides and Proteins

May 15, 2025

Constructive Bio Highly Commended for Biotech Company of the Year at Cambridge Independent Science Awards

April 7, 2025

Constructive Bio Named ‘Biotech One to Watch’ in The Sunday Times 100 Tech Awards 2025

March 18, 2025

Constructive Bio CEO Ola Wlodek Presents on Genetic Code Expansion at Milner Therapeutics Institute

Genetic code expansion to manufacture proteins with chemistries nature never made

September 24, 2024

Constructive Bio Raises $58M Series A to Scale Fermentation-Based Peptide Manufacturing with Non-Canonical Amino Acids

Professor Jason Chin Reappointed to UK Department for Science, Innovation and Technology Board

April 26, 2024

Professor Jason Chin Reappointed to UK Department for Science, Innovation and Technology Board

November 15, 2023

Constructive Bio Expands to New Cambridge Headquarters at The Recodery in the Cambridge Biomedical Cluster

August 14, 2022

Financial Times Profiles Constructive Bio’s Synthetic Genomics and Genetic Code Engineering